Respiratory Distress Syndrome

Slides:



Advertisements
Similar presentations
Late Exogenous Surfactant Therapy In Preterm Neonates With Respiratory Distress Syndrome By Dr. Mohamed El- Sherbini.
Advertisements

Pediatric Fundamentals Prematurity Drs. Greg and Joy Loy Gordon January 2005.
Respiratory problems in premature infants
Respiratory distress Cause of significant morbidity and mortality
High Risk Neonatal Nursing Care
Respiratory Distress Syndrome
Signs, Symptoms and Findings: Towards an Ontology for Clinical Phenotypes Milan, September 4-5, 2009 Structured Representation of Disorders of the Newborn.
Transient Tachypnea of the Newborn
CONGENITAL AND ACQUIRED RESPIRATORY DISORDERS IN INFANTS.
Neonatal Respiratory Distress
MECONIUM ASPIRATION SYNDROME
Respiratory distress in newborn 4 th year seminar.
1 URINALYSIS AND BODY FLUIDS (AMNIOTIC FLUID) LECTURE Dr. Essam H. Jiffri.
Meconium Aspiration Syndrome Edited May  PO 2 L --> R ductus arteriosus shunt Ventilation Remove Placenta Ductus Venosus Closes  Systemic Vascular.
Infant Of Diabetic Mother LALEH GHANEI,MD, Endocrinology Fellow,Endocrinology Research Center Taleghani Hospital.
RT 256 Idiopathic (Infant) Respiratory Distress Syndrome.
Andrew G James Signs, Symptoms and Findings: First Steps Dallas, TX. September 3-4, 2008 Toward an Ontology for Clinical Phenotype Clinical signs and findings.
RESPIRATORY DISTRESS SYNDROME
Critical Neonate Rafat Mosalli MD. Objectives Describe the algorithm for neonatal resuscitation and Delivery room management Describe the algorithm for.
The single most important cause of mortality and morbidity in preterm infants Bianca Marie Moses.
PAL – Distressed Newborn
Part 2 by Yong.  Most common cause of respiratory distress.  40% cases.  Residual fluid in fetal lung tissues.  Risk factors- maternal asthma, c-
Hugo A. Navarro, M.D. Medical Director SCN Alamance Regional Medical Center Assistant Professor DUMC.
Elective Cesarean Delivery, Neonatal Intensive Care Unit Admission, and Neonatal Respiratory Distress 楊明智.
 By:Sh.Nariman MD,Neonatologist  Tehran University of medical Sciences  Arash Women Hospital.
Respiratory distress 1-tachypnea (RR>60/min)
TREATMENT. Hyaline Membrane Disease Prenatal prevention and prediction –Prevent premature birth with tocolytics, antibiotics to address ongoing infection.
Respiratory Distress in Newborn
Neonatal Respiratory Distress Syndrome NRDS 新生儿呼吸窘迫综合征 Pediatric department of First Affiliated Hospital of Shantou university medical college Lin Niyang.
Complications of Prematurity. Neonatal mortality Causes of neonatal death in Cambridge Maternity Hospital Respiratory distress syndrome137*38.
Hyaline Membrane Disease Vincent Patrick Uy. Infant’s First Breath Intermittent compression of the thorax facilitates removal of lung fluids Surfactant.
Divisions of Critical Care Medicine*, Pulmonology ¶, Department of Pediatrics #, and Department of Pathology §, Advocate Lutheran General Children’s Hospital.
Infant of a Diabetic Mother. Introduction Frequency: 3-10% of pregnant women have diabetes  88% have gestational diabetes  12% have known diabetes 
Author: Nagy Iulia Andrea Coordinator: Simon Márta, PhD, Lecturer Coauthor: Ortopan Maria, Oana Andrea Edina.
Rafat Mosalli MD Abnormal Gestation. Objectives What is Normal gestation? What is Normal gestation? Newborn classification according to age and Weight.
 30,000 live births from  Compared courses of babies of weeks to those of 39 weeks or longer.
Respiratory Distress Syndrome 1454 Uzair Siddiqi.
Maria Victoria B. Pertubal M.D. PGY1
Respiratory Respiratory Failure and ARDS. Normal Respirations.
DISEASES OF ALVEOLAR HOMEOSTASIS: RDS and BPD
Neonatal Diseases.
Respiratory Distress Syndrome (RDS)
Nonatology: Neonatal Respiratory Distress Lecture Points Neonatal pulmonary function Clinical Manifestation The main causes Main types of the disease.
Respiratory disorders
Respiratory Distress Syndrome Hyaline Membrane Disease
Bronchiolitis Abdullah M. Al-Olayan MBBS, SBP, ABP. Assistant Professor of Pediatrics. Pediatric Pulmonologist.
Respiratory Disorders Respiratory Disorders in the Newborn PERINATOLOGY.
Nursing Care of newborn
Department of Child Health Medical School University of Sumatera Utara
Neonatal Respiratory Distress Syndrome (NRDS ). Purpose To be familiar with etiology and mechanism To master clinical manifestation and differential diagnosis.
Respiratory Distress in the Newborn
PNEUMONIA BY: NICOLE STEVENS.
Diagnostic Medical Sonography Program
Respiratory Distress Syndrome IAP UG Teaching slides
Diagnostic Medical Sonography Program
Nursing Care of newborn
RESPIRATORY DISTRESS SYNDROME IN NEONATES
Transient Tachypnea of newborn Wet lung; RDSII (TTN)
RSTH 421 PEDIATRIC PERINATAL RESPIRATORY CARE  
Persistent Pulmonary Hypertension of the Newborn
DEFINITION Respiratory problem in premature babies
Meconium aspiration syndrome
Neonatal Nursing Care Neonatal Complications
Respiratory Disorders of the Newborn Infants
Hyaline Membrane Disease
Development of respiratory system [except nose]
IDIOPATHIC RESPIRATORY DISTRESS SYNDROME
Atelectasis, acute respiratory distress syndrome & pulmonary edema
Neonatal Respiratory Distress Syndrome NRDS 新生儿呼吸窘迫综合征
Fetal Distress Dr. Mahboubeh Valiani Academic Member of IUMS
Presentation transcript:

Respiratory Distress Syndrome Resident Lecture Series Soo Hyun Kwon, MD Neonatal-Perinatal Fellow

Overview Definition Epidemiology Lung Development Pathophysiology Risk Factors Clinical Manifestations DDx Diagnosis Treatment

Objectives Define respiratory distress syndrome (RDS). Discuss the epidemiology, pathophysiology, and diagnosis of RDS. List a differential diagnosis for respiratory distress in the neonate. Describe the treatments for RDS. Discuss ventilation strategies that can be used in the infant who has RDS. Describe long-term complications of RDS and its treatments.

Definition Formerly known as hyaline membrane disease Deficiency of pulmonary surfactant in an immature lung Disease of prematurity

Epidemiology Major cause of morbidity and mortality in preterm infants 20,000-30,000 newborn infants each year Incidence and severity of RDS are related inversely to gestational age of newborn infant 26-28 weeks' gestation : 50% 30-31 weeks' gestation : <30% Overall incidence in 501-1500 grams: 42% 501-750 grams: 71% 751-1000 grams: 54% 1001-1250 grams: 36% 1251-1500 grams: 22%

Phases of Lung Development Normal alveolar development occurs in 4 stages. Embryonic period – At about 26 days gestation, the embryonic stage begins with the first appearance of the fetal lung, which appears as a protrusion of the foregut. Initial branching of the lung occurs at 33 days gestation forming the prospective main bronchi, which begin to extend into the mesenchyme. Further branching forms the segmental bronchi as the lung enters the next stage of development. Pseudoglandular stage – 7th to 16th weeks of gestation, 15 to 20 generations of airway branching occur starting from the main segmental bronchi and ending as terminal bronchioles. end of the pseudoglandular stage, airways are surrounded by a loosely packed mesenchyme, which includes a few blood vessels, and is lined by glycogen-rich and morphologically undifferentiated epithelial cells with a columnar to cuboidal shape. In general, epithelial differentiation is centrifugal so the most distal tubules are lined with undifferentiated cells with progressive epithelial differentiation of the more proximal airways. Canalicular stage – 16th and 25 weeks gestation, transition from previable to a potential viable lung occurs as the respiratory bronchioles and alveolar ducts of the gas exchange region of the lung are formed. The surrounding mesenchyme becomes more vascular and condenses around the airways. The closer vascular proximity ultimately results in fusion of the capillary and epithelial basement membranes. After 20 weeks gestation, cuboidal epithelial cells begin to differentiate into alveolar type II cells with formation of cytoplasmic lamellar bodies [2]. The glycogen in these cells is used for surfactant production, which is stored in the lamellar bodies. Saccular stage – About 24 weeks gestation, there is potential for viability because gas exchange is possible due to the presence of large and primitive forms of the future alveoli. In this stage, formation of alveoli (ie, alveolarization) occurs by the outgrowth of septae that subdivide terminal saccules into anatomic alveoli, where air exchange occurs. The number of alveoli in each lung increases from zero at 32 week gestation to between 50 and 150 million alveoli in term infants and 300 million in adults. Alveolar growth continues for at least two years after birth at term.

Lung Development

Surfactant Complex lipoprotein Composed of 6 phospholipids and 4 apoproteins 70-80% phospholipids, 8-10% protein, and 10% neutral lipids

Surfactant Metabolism Surfactant components are synthesized from precursors in the endoplasmic reticulum and transported through the Golgi apparatus by multivesicular bodies. Components are ultimately packaged in lamellar bodies, which are intracellular storage granules for surfactant before its secretion. After secretion (exocytosis) into the liquid lining of the alveolus, surfactant phospholipids are organized into a complex lattice called tubular myelin. Tubular myelin is believed to generate the phospholipid that provides material for a monolayer at the air-liquid interface in the alveolus, which lowers surface tension. Surfactant phospholipids and proteins are subsequently taken back into type II cells, in the form of small vesicles, apparently by a specific pathway that involves endosomes, and then are transported for storage into lamellar bodies for recycling. Alveolar macrophages also take up some surfactant in the liquid layer. A single transit of the phospholipid components of surfactant through the alveolar lumen normally requires a few hours. The phospholipid in the lumen is taken back into type II cell and is reused 10 times before being degraded. Surfactant proteins are synthesized in polyribosomes and extensively modified in the endoplasmic reticulum, Golgi apparatus, and multivesicular bodies. Surfactant proteins are detected in lamellar bodies or secretory vesicles closely associated with lamellar bodies before they are secreted into the alveolus.

Assessment of Fetal Lung Maturity Lecithin/sphingomyelin (L/S) ratio Lamellar body counts Phosphatidylglycerol After 35 weeks gestation

L/S Ratio Amniotic fluid L/S ratio increases progressively with gestational age. L/S ratio greater than two signifies maturity of surfactant system of lung

Pathophysiology Hypoxia, acidosis, hypothermia, hypotension - Surfactant deficiency - Inflammation and Lung injury - Pulmonary edema - Surfactant inactivation - Pulmonary function and gas exchange Impaired surfactant synthesis and secretion  atelectasis, V/Q inequality, hypoventilation  hypoxemia and hypercarbia Respiratory / metabolic acidosis  pulmonary vasoconstriction  impaired endothelial and epithelial integrity  leakage of proteinaceous exudate and formation of hyaline membranes Deficiency of surfactant  decreases lung compliance and FRC, with increased dead space Impair surfactant production and/or secretion Hypoxia, acidosis, hypothermia, hypotension Oxygen toxicity  influx of inflammatory cell  exacerbates vascular injury  BPD Antioxidant deficiency and free-radical injury worsen injury

Etiology Preterm delivery Mutations in genes encoding surfactant proteins SP-B SP-C ATP-binding cassette (ABC) transporter A3 (ABCA3)

Lung Compliance Lungs with HMD require far more pressure than to achieve a given volume of inflation than do lungs obtained from an infant dying of a nonrespiratory cause. Arrows indicate inspiratory and expiratory limbs of the pressure-volume curves. Note the decreased lung compliance and increased critical opening and closing pressures, respectively, in the premature infant with HMD

Normal Lung

Hyaline Membranes line the alveoli (see the image below) may form within a half hour after birth. In larger premature infants, the epithelium begins to heal at 36-72 hours after birth, and endogenous surfactant synthesis begins. The recovery phase is characterized by regeneration of alveolar cells, including type II cells, with a resultant increase in surfactant activity.

Risk Factors Prematurity Maternal diabetes C-section delivery Asphyxia

Surfactant Inactivation Meconium and blood can inactivate surfactant activity (Full-term > Preterm) Proteinaceous edema and inflammatory products increase conversion rate of surfactant into its inactive vesicular form Oxidant and mechanical stress associated with mechanical ventilation that uses large TV

Clinical Manifestations Tachypnea Nasal flaring Grunting Intercostal, subxiphoid, and subcostal retractions Cyanosis

Differential Diagnosis TTN MAS Pneumonia Cyanotic Congenital Heart Disease Pneumomediastinum, pneumothorax Hypoglycemia Metabolic problems Hematologic problems Anemia, polycythemia Congenital anomalies of the lungs

Diagnosis Onset of progressive respiratory failure shortly after birth Characteristic chest radiograph ABG Hypoxia Hypercarbia

CXR low lung volume and the classic diffuse reticulogranular ground-glass appearance with air bronchograms

Prevention Antenatal glucocorticoids Enhances maturational changes in lung architecture and inducing enzymes Stimulate phospholipid synthesis and release of surfactant All pregnant mothers at risk for preterm delivery at or below 34 weeks gestation should receive ACS two doses of betamethasone administered 24 hours apart is currently the recommended steroid for antenatal use Antenatal steroid administration has been shown to be beneficial if provided fewer than 24 hours before delivery Furthermore, a reduction in RDS has been seen in infants born up to 7 days after the first dose of antenatal steroids was administered. (1) No benefit is seen in infants who receive the first dose of steroids more than 7 days before birth. They recommend repeat doses of corticosteroids in women at risk for preterm birth when the first course of steroids was administered more than 7 days previously because of the short-term benefits to the fetal lungs. They do, however, warn about the possibility of decreased birthweight and head circumference at birth, which has been reported.

Treatment Surfactant Therapy Assisted Ventilation Techniques Supportive Care Thermoregulation Fluid Management Nutrition Surfactant complications: apnea, brady, desats, pulm hemorrhage

References Jobe AH. Why Surfactant Works for Respiratory Distress Syndrome. NeoReviews. 2006; 7: 95-106. Pramanik AK, et al. Respiratory distress syndrome. http://emedicine.medscape.com/article/976034-overview. Saker F, Martin R. Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn. Uptodate. http://www.utdol.com Warren JB, Andersen JM. Respiratory distress syndrome. Neoreviews. 2009; 7: 351-361.

Questions or Comments?